Lyme disease: Is it or is it not?

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 16, Issue 6, 2005, Pages 325-328

  Johnston, B L ^a,c   Conly, J M ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CEFUROXIME; DOXYCYCLINE; ERYTHROMYCIN; PENICILLIN G; TETRACYCLINE;

BALANCE DISORDER; BORRELIA BURGDORFERI; CLINICAL FEATURE; DIZZINESS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOFLUORESCENCE TEST; IXODES DAMMINI; LYME DISEASE; MUSCLE TWITCH; REVIEW; THORAX PAIN; TICK BITE;

EID: 30644464196     PISSN: 17129532     EISSN: None     Source Type: Journal    
DOI: 10.1155/2005/278304     Document Type: Review

References (46)

1. Bourette S. Ticking bomb? The Globe and Mail, section F1, August 20, 2005. 〈http://www.theglobeandmail.com/servlet/story/ RTGAM.20050820. wticks20/BNStory/specialScienceandHealth〉 (Version current at November 9, 2005).
2. Feder HM Jr. Differences are voiced by two Lyme camps at a Connecticut public hearing on insurance coverage of Lyme disease. Pediatrics 2000;105:855-7.
3. Steere AC, Malawista SE, Snydman DR, et al. Lyme arthritis: An epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 1977;20:7-17.
4. Steere AC, Grodzicki RL, Kornblatt AN, et al. The spirochetal etiology of Lyme disease. N Engl J Med 1983;308:735-40.
5. Benach JL, Bosler EM, Hanrahan JP, et al. Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med 1983;308:740-2.
6. Harris ED Jr. Lyme disease - success for academia and the community. N Engl J Med 1983;308:773-5.
7. Centers for Disease Control and Prevention. Notifiable diseases/deaths in selected cities weekly information. MMWR Morb Mortal Wkly Rep 2004;53:1213-21.
8. Steere AC. Lyme disease: A growing threat to urban populations. Proc Natl Acad Sci USA 1994;91:2378-83.
9. Lindsay R, Artsob H, Galloway T, Horsman G. Vector of Lyme borreliosis, Ixodes scapularis, identified in Saskatchewan. Can Commun Dis Rep 1999;25:81-3.
10. Public Health Agency of Canada. Lyme disease. 〈www.phac-aspc.gc.ca/ id-mi/pdf/lyme-fs_e.pdf〉 (Version current at November 9, 2005).
11. Government of Ontario. Diseases: Lyme disease. 〈www.health.gov.on. ca/ english/public/pub/disease/pdf/lyme.pdf〉 (Version current at November 9, 2005).
12. Shapiro ED, Gerber MA, Holabird NB, et al. A controlled trial of antimicrobial prophylaxis for Lyme disease after deer-tick bites. N Engl J Med 1992;327:1769-73.
13. Nadelman RB, Nowakowski J, Fish D, et al. Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N Engl J Med 2001;345:79-84.
14. Sigal LH, Zahradnik JM, Lavin P, et al. A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium. N Engl J Med 1998;339:216-22. (Erratum in 1998;339:571).
15. Steere AC, Sikand VK, Meurice F, et al. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. N Engl J Med 1998;339:209-15.
16. Steere AC, Sikand VK. The presenting manifestations of Lyme disease and the outcomes of treatment. N Engl J Med 2003;348:2472-4.
17. Petersen LR, Sweeney AH, Checko PJ, et al. Epidemiological and clinical features of 1,149 persons with Lyme disease identified by laboratory-based surveillance in Connecticut. Yale J Biol Med 1989;62:253-62.
18. Feder HM Jr, Whitaker DL. Misdiagnosis of erythema migrans. Am J Med 1995;99:412-9.
19. Malane MS, Grant-Kels JM, Feder HM Jr, Luger SW. Diagnosis of Lyme disease based on dermatologic manifestations. Ann Intern Med 1991;114:490-8.
20. Steere AC. Lyme disease. N Engl J Med 1989;321:586-96.
21. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of lyme borreliosis. Clin Microbiol Rev 2005;18:484-509.
22. Bakken LL, Case KL, Callister SM, Bourdeau NJ, Schell RF. Performance of 45 laboratories participating in a proficiency testing program for Lyme disease serology. JAMA 1992;268:891-5.
23. Bakken LL, Callister SM, Wand PJ, Schell RF. Interlaboratory comparison of test results for detection of Lyme disease by 516 participants in the Wisconsin State Laboratory of Hygiene/College of American Pathologists Proficiency Testing Program. J Clin Microbiol 1997;35:537-43.
24. Centers for Disease Control and Prevention. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep 1995;44:590-1.
25. Mitchell PD, Reed KD, Aspeslet TL, Vandermause MF, Melski JW. Comparison of four immunoserologic assays for detection of antibodies to Borrelia burgdorferi in patients with culture-positive erythema migrans. J Clin Microbiol 1994;32:1958-62. (Erratum in 1994;32:2343).
26. Aguero-Rosenfeld ME, Nowakowski J, McKenna DF, Carbonaro CA, Wormser GP. Serodiagnosis in early Lyme disease. J Clin Microbiol 1993;31:3090-5. (Erratum in 1994;32:860).
27. Russell H, Sampson JS, Schmid GP, Wilkinson HW, Plikaytis B. Enzyme-linked immunosorbent assay and indirect immunofluorescence assay for Lyme disease. J Infect Dis 1984;149:465-70.
28. Aguero-Rosenfeld ME, Nowakowski J, Bittker S, Cooper D, Nadelman RB, Wormser GP. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol 1996;34:1-9.
29. CDC. Notice to Readers: Caution regarding testing for Lyme disease. MMWR Morb Mortal Wkly Rep 2005;54:125.
30. Steere AC, Malawista SE, Newman JH, Spieler PN, Bartenhagen NH. Antibiotic therapy in Lyme disease. Ann Intern Med 1980;93:1-8.
31. Steere AC, Hutchinson GJ, Rahn DW, et al. Treatment of the early manifestations of Lyme disease. Ann Intern Med 1983;99:22-6.
32. Nadelman RB, Luger SW, Frank E, Wisniewski M, Collins JJ, Wormser GP. Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease. Ann Intern Med 1992;117:273-80.
33. Wormser GP, Ramanathan R, Nowakowski J, et al. Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2003;138:697-704.
34. Dattwyler RJ, Luft BJ, Kunkel MJ, et al. Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease. N Engl J Med 1997;337:289-94.
35. Klempner MS, Hu LT, Evans J, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 2001;345:85-92.
36. Wormser GP, Nadelman RB, Dattwyler RJ, et al. Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America. Clin Infect Dis 2000;31(Suppl 1):1-14.
37. Nowakowski J, Nadelman RB, Sell R, et al. Long-term follow-up of patients with culture-confirmed Lyme disease. Am J Med 2003;115:91-6.
38. Shadick NA, Phillips CB, Logigian EL, et al. The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann Intern Med 1994;121:560-7.
39. Shadick NA, Phillips CB, Sangha O, et al. Musculoskeletal and neurologic outcomes in patients with previously treated Lyme disease. Ann Intern Med 1999;131:919-26.
40. Kaplan RF, Trevino RP, Johnson GM, et al. Cognitive function in post-treatment Lyme disease. Do additional antibiotics help? Neurology 2003;60:1916-22.
41. Seltzer EG, Gerber MA, Cartter ML, Freudigman K, Shapiro ED. Long-term outcomes of persons with Lyme disease. JAMA 2000;283:609-16.
42. Sigal LH. Summary of the first 100 patients seen at a Lyme disease referral center. Am J Med 1990;88:577-81.
43. Steere AC, Taylor E, McHugh GL, Logigian EL. The overdiagnosis of Lyme disease. JAMA 1993;269:1812-6.
44. Reid MC, Schoen RT, Evans J, Rosenberg JC, Horwitz RI. The consequences of overdiagnosis and overtreatment of Lyme disease: An observational study. Ann Interm Med 1998;128:354-62.
45. Ramsey AH, Belongia EA, Chyou PH, Davis JP. Appropriateness of Lyme disease serologic testing. Ann Family Med 2004;2:341-4.
46. Rodriquez LAG, Gonzalez-Perez A. Use of antibiotics and risk of breast cancer. Am J Epidemiol 2005;161:616-9.